Clinicopathological significance of cuproptosis-related genes DLD, LIAS, and PDHA1 in bladder cancer

Abstract Bladder cancer (BC) is the most common malignancy of the urinary tract, with high recurrence rates and frequent progression. Cuproptosis is a copper-dependent form of regulated cell death and a potential contributor to tumorigenesis; however, clinical evidence regarding the role of cuproptosis-related genes in BC remains limited. This study investigated the expression of DLD , LIAS , and PDHA1 in BC tissues. Gene expressions were quantified by RT-qPCR in 62 BC and 38 non-neoplastic bladder tissues. Clinicopathological associations were assessed, and diagnostic performance was evaluated using receiver operating characteristic (ROC) analysis and multivariable logistic regression. Analyses revealed that LIAS expression was significantly lower in tumor tissues than in non-neoplastic tissues, showing a 1.59-fold reduction ( P = 0.036), whereas DLD and PDHA1 showed no significant differences. All three genes were significantly downregulated in muscle-invasive (MIBC) compared to non-muscle-invasive (NMIBC) tumors ( DLD , P = 0.001; LIAS , P < 0.001; PDHA1 , P = 0.030). Furthermore, lower DLD and LIAS expressions were significantly associated with advanced pathological stages and higher tumor grades ( P < 0.05). Individually, the genes showed limited discriminatory performance, with area under the curve (AUC) values ranging from 0.54 to 0.63. However, their combined model showed improved performance, yielding an AUC of 0.81. Collectively, these findings indicate that DLD , LIAS , and PDHA1 expression levels are associated with tumor status and clinicopathological features in BC. Such patterns may reflect metabolic changes that alter tumor cell susceptibility to copper-dependent cell death, although the underlying biological mechanisms remain to be determined. The combined expression profile may have preliminary utility as an exploratory discriminatory panel for BC. However, this study did not directly evaluate cuproptosis activity or establish a mechanistic or causal relationship between these genes and copper-dependent cell death; validation in larger, independent cohorts is required.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-13
DOI
https://doi.org/10.1038/s41598-026-79591-y
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinicopathological significance of cuproptosis-related genes DLD, LIAS, and PDHA1 in bladder cancer

Ali Ariafar, Ehsan Nazemalhosseini Mojarad, Mona Entezam, Zahra Sadat Faghih et al.
Scientific Reports
Bladder and Urothelial Cancer Treatments
article

Clinicopathological significance of cuproptosis-related genes DLD, LIAS, and PDHA1 in bladder cancer

Ali Ariafar, Ehsan Nazemalhosseini Mojarad, Mona Entezam, Zahra Sadat Faghih, Amin Ramezani, Sheyda Homayoon
article en

Abstract

Abstract Bladder cancer (BC) is the most common malignancy of the urinary tract, with high recurrence rates and frequent progression. Cuproptosis is a copper-dependent form of regulated cell death and a potential contributor to tumorigenesis; however, clinical evidence regarding the role of cuproptosis-related genes in BC remains limited. This study investigated the expression of DLD , LIAS , and PDHA1 in BC tissues. Gene expressions were quantified by RT-qPCR in 62 BC and 38 non-neoplastic bladder tissues. Clinicopathological associations were assessed, and diagnostic performance was evaluated using receiver operating characteristic (ROC) analysis and multivariable logistic regression. Analyses revealed that LIAS expression was significantly lower in tumor tissues than in non-neoplastic tissues, showing a 1.59-fold reduction ( P = 0.036), whereas DLD and PDHA1 showed no significant differences. All three genes were significantly downregulated in muscle-invasive (MIBC) compared to non-muscle-invasive (NMIBC) tumors ( DLD , P = 0.001; LIAS , P < 0.001; PDHA1 , P = 0.030). Furthermore, lower DLD and LIAS expressions were significantly associated with advanced pathological stages and higher tumor grades ( P < 0.05). Individually, the genes showed limited discriminatory performance, with area under the curve (AUC) values ranging from 0.54 to 0.63. However, their combined model showed improved performance, yielding an AUC of 0.81. Collectively, these findings indicate that DLD , LIAS , and PDHA1 expression levels are associated with tumor status and clinicopathological features in BC. Such patterns may reflect metabolic changes that alter tumor cell susceptibility to copper-dependent cell death, although the underlying biological mechanisms remain to be determined. The combined expression profile may have preliminary utility as an exploratory discriminatory panel for BC. However, this study did not directly evaluate cuproptosis activity or establish a mechanistic or causal relationship between these genes and copper-dependent cell death; validation in larger, independent cohorts is required.

Scientific Reports
Shiraz University of Medical Sciences (IR), Tehran University of Medical Sciences (IR)
Good health and well-being
Bladder and Urothelial Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon